» Articles » PMID: 10818091

Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule Assembly

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 May 20
PMID 10818091
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

In Alzheimer's disease, hyperphosphorylated tau is an integral part of the neurofibrillary tangles that form within neuronal cell bodies and fails to promote microtubule assembly. Dysregulation of the brain-specific tau protein kinase II is reported to play an important role in the pathogenesis of Alzheimer's disease (Patrick, G. N., Zukerberg, L., Nikolic, M., De La Monte, S., Dikkes, P., and Tsai, L.-H. (1999) Nature 402, 615-622). We report here that in vitro phosphorylation of human tau by human recombinant tau protein kinase II severely inhibits the ability of tau to promote microtubule assembly as monitored by tubulin polymerization. The ultrastructure of tau-mediated polymerized tubulin was visualized by electron microscopy and compared with phosphorylated tau. Consistent with the observed slower kinetics of tubulin polymerization, phosphorylated tau is compromised in its ability to generate microtubules. Moreover, we show that phosphorylation of microtubule-associated tau results in tau's dissociation from the microtubules and tubulin depolymerization. Mutational studies with human tau indicate that phosphorylation by tau protein kinase II at serine 396 and serine 404 is primarily responsible for the functional loss of tau-mediated tubulin polymerization. These in vitro results suggest a possible role for tau protein kinase II-mediated tau phosphorylation in initiating the destabilization of microtubules.

Citing Articles

Serine phosphorylation facilitates protein degradation by the human mitochondrial ClpXP protease.

Feng Y, Goncalves M, Jitkova Y, Keszei A, Yan Y, Sarathy C Proc Natl Acad Sci U S A. 2025; 122(5):e2422447122.

PMID: 39879245 PMC: 11804671. DOI: 10.1073/pnas.2422447122.


Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.

Abou Assi L, Alkhansa S, Njeim R, Ismail J, Madi M, Ghadieh H Pharmaceutics. 2024; 16(7).

PMID: 39065652 PMC: 11279906. DOI: 10.3390/pharmaceutics16070955.


The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.

Buchholz S, Zempel H Alzheimers Dement. 2024; 20(5):3606-3628.

PMID: 38556838 PMC: 11095451. DOI: 10.1002/alz.13784.


Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation.

Ramirez E, Ganegamage S, Min S, Patel H, Ogunware A, Plascencia-Villa G ACS Chem Neurosci. 2023; 14(21):3913-3927.

PMID: 37818657 PMC: 10624178. DOI: 10.1021/acschemneuro.3c00464.


Gliosis, misfolded protein aggregation, and neuronal loss in a guinea pig model of pulmonary tuberculosis.

Latham A, Geer C, Ackart D, Anderson I, Vittoria K, Podell B Front Neurosci. 2023; 17:1157652.

PMID: 37274195 PMC: 10235533. DOI: 10.3389/fnins.2023.1157652.